BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12608116)

  • 1. Supply and demand: negotiating the prescription drug labyrinth to reduce costs.
    DeStefino K
    Benefits Q; 2003; 19(1):30-7. PubMed ID: 12608116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the intricate Web of prescription drugs.
    Eber BL
    Benefits Q; 2003; 19(1):45-50. PubMed ID: 12608118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Employers push to manage prescription drug costs.
    Frieden J
    Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug benefits: promising solutions.
    Goff VV
    Issue Brief (Inst Health Care Costs Solut); 2002; 1(4):1-16. PubMed ID: 12825600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prescription card service and mail-order drug programs on employers' prescription drug costs.
    Cave DG
    Benefits Q; 1994; 10(4):21-30. PubMed ID: 10138423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choices in prescription-drug benefit programs: mail versus community pharmacy services.
    Kirking DM; Ascione FJ; Richards JW
    Milbank Q; 1990; 68(1):29-51. PubMed ID: 2215427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG
    Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing an effective generic prescription drug program.
    Jones JD
    Benefits Q; 2003; 19(1):14-8. PubMed ID: 12608114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of prescription costs--is it possible?
    Renaud PN
    Empl Benefits J; 2002 Mar; 27(1):11-4. PubMed ID: 11859536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keeping prescription drugs affordable.
    Arp D
    Healthplan; 2002; 43(6):12-5. PubMed ID: 12506430
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription drug benefits: Rx for cost management--commentary.
    Carlsen MA
    Benefits Q; 1993; 9(3):81-8. PubMed ID: 10127207
    [No Abstract]   [Full Text] [Related]  

  • 14. Employer strategies in managing prescription drug costs.
    Rubinstein E
    Bus Health; 1991 Jan; 9(1):26, 28-30, 34-5. PubMed ID: 10108955
    [No Abstract]   [Full Text] [Related]  

  • 15. PBM industry today: who's managing drug costs?
    Martin SS
    Manag Care; 2001 Dec; 10(12):36-8. PubMed ID: 11795000
    [No Abstract]   [Full Text] [Related]  

  • 16. The drug cost gap and the diagnosis-prescription connection.
    Dross D
    Benefits Q; 2008; 24(4):29-32. PubMed ID: 19048746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seeking value in working with pharmacy benefit managers.
    Vogenberg FR; Sica JM
    Benefits Q; 2003; 19(1):7-12. PubMed ID: 12608113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing prescription drug costs: a case study.
    DuBois RW; Feinberg PE
    Med Interface; 1994 Jun; 7(6):65-8, 70, 74. PubMed ID: 10135321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring drug compliance can reduce total medical plan costs.
    Mandelker J
    Bus Health; 1993 May; 11(6):26-7, 31-5. PubMed ID: 10126109
    [No Abstract]   [Full Text] [Related]  

  • 20. Getting a handle on health fund finances: a comprehensive but practical approach.
    Blumenstein D; Kaplan EA
    Empl Benefits J; 2003 Sep; 28(3):3-5. PubMed ID: 12964527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.